TY - JOUR
AU - J. Miles
AU - P. Treitler
AU - R. Hermida
AU - A. N. Nyaku
AU - K. Simon
AU - S. Gupta
AU - S. Crystal
AU - H. Samples
A1 - 
AD - Rutgers Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA. Electronic address: jm2462@ssw.rutgers.edu.;Rutgers Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA; School of Social Work, Rutgers University, New Brunswick, NJ, USA.;Rutgers Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA.;Department of Medicine, Division of Infectious Diseases, Rutgers New Jersey Medical School, Newark, NJ, USA.;O'Neill School of Public and Environmental Affairs, Indiana University, Bloomington, IN, USA; National Bureau of Economic Research, Cambridge, MA, USA.;Department of Economics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, USA.;Rutgers Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA; School of Social Work, Rutgers University, New Brunswick, NJ, USA; School of Public Health, Rutgers University, Piscataway, NJ, USA.;Rutgers Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA; Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, NJ, USA.
AN - 37748421
BT - Drug Alcohol Depend
C5 - Healthcare Disparities;Opioids & Substance Use;Financing & Sustainability
DA - Sep 14
DO - 10.1016/j.drugalcdep.2023.110963
DP - NLM
ET - 20230914
JF - Drug Alcohol Depend
LA - eng
PY - 2023
SN - 0376-8716
SP - 110963
ST - Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries
T1 - Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries
T2 - Drug Alcohol Depend
TI - Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries
U1 - Healthcare Disparities;Opioids & Substance Use;Financing & Sustainability
U3 - 10.1016/j.drugalcdep.2023.110963
VL - 252
VO - 0376-8716
Y1 - 2023
ER -